What makes a great surgeon? Specialty knowledge, technical skill … and professionalism. Written by Professor Steve Payne and subject experts, this free eBook brings together 17 in-depth articles on the non-medical skills and competencies required of a medical professional. Whether you’re a trainee just starting out or an experienced consultant, the authors’ invaluable advice will help you make better decisions for yourself and those in your care.
What is professionalism?
Maintaining good medical practice
Communicating in the 21st century
Keeping up to date
Click here to access your free copy for mobile, desktop or e-readers: eBook
BJUI Compass is delighted to announce our new Editor-in-Chief, Michael A. Gorin, M.D.
Michael A Gorin, the new Editor-in-Chief of BJUI Compass
Dr Gorin is an Associate Professor of Urology in the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. He is an internationally recognized expert on the use of molecular imaging techniques in the diagnosis and management of urologic malignancies. He is also widely recognized for his work developing novel methods for performing MRI-guided transperineal prostate biopsy and focal ablative treatments for prostate cancer. As a fellowship-trained endourologist, Dr. Gorin’s clinical practice primarily focuses on caring for patients with kidney stones, lower urinary tract symptoms, and prostate cancer.
Dr. Gorin has published over 275 articles in peer-reviewed journals with collaborators from around the world. Additionally, he has contributed to multiple medical textbooks, including chapters in Campbell-Walsh-Wein Urology, The 5-Minute Urology Consult, and Gray’s Anatomy. In July 2022, Dr. Gorin was selected as the new Editor-in-Chief of BJUI Compass, the open-access companion journal to the BJU International. Dr. Gorin also serves on the editorial boards of several other journals, including UROLOGY (the Gold Journal), Urologic Oncology: Seminars and Original Investigations, and the World Journal of Urology. Dr. Gorin has received numerous honors and awards for his scholarly work, including the Drs. Carl and Barbara Alving Endowed Award for Outstanding Biomedical Research from the University of Miami Miller School of Medicine and the William F. Rienhoff, Jr., M.D. Scholar Award from Johns Hopkins University School of Medicine.
Dr. Gorin attended college at the University of Michigan, earning a Bachelor of Science in Cellular and Molecular Biology. He then attended medical school at the University of Miami Leonard M. Miller School of Medicine, where he graduated as an inductee to the Alpha Omega Alpha Honor Medical Society. Following medical school, Dr. Gorin completed a general surgery internship, urology residency, and fellowship in endoscopic and minimally invasive urology at the James Buchanan Brady Urological Institute at Johns Hopkins University School of Medicine.
BJU International is seeking to appoint an Editor for BJUI Compass.
BJUI Compass is an online-only, fully open access journal and is part of the overall academic BJU International family including the flagship BJU International (BJUI) journal, BJUI Compass, and the e-learning platform, BJUI Knowledge. The journal is owned by BJU International charity and published by Wiley.
If you are interested in this role, please email Sophia Anderton, BJUI Chief Executive, at [email protected] providing your curriculum vitae and a covering letter explaining why you are interested and what you think you have to offer by 2 May 2022. You are welcome to get in touch if you would like an informal conversation about the role.
We will acknowledge receipt of your email. It is possible that we may request further information from you.
Shortlisted candidates will be invited to meet the Trustees on 18 May 2022. When applying please ensure you can be available for this date.
The final decision on this appointment will be made by the Trustees who will meet the final shortlist of candidates.
The role of Editor
The journal covers the entire breadth of urology including epidemiology, urological oncology, surgery, reconstruction, benign disease, upper urinary tract, functional urology, andrology and sexual function. The overriding theme of BJUI Compass is to support “sound science criteria”. This means that every piece of research that has been conducted in a sound and rigorous manner should be published somewhere. BJUI Compass can therefore include papers that are:
mostly confirmatory knowledge
clinical trials or comparative evidence that are negative
novel concepts that may lack enough sample size or global population representation.
The Editor of this journal will work under the Editor-in-Chief of BJU International, Professor Freddie Hamdy.
A fee will be paid to the Editor for this role. The role and responsibilities of the Editor, with the support of an Editorial Team, the Editorial Office Team and Chief Executive, include:
Implementation of the publication objectives and strategy agreed with the BJUI Editor-in-Chief and the Trustees of BJUI
Timely management of the process of submissions
Working with the BJUI Editorial team to encourage offers of transfer (cascade) from BJUI to BJUI Compass
Encouraging high-quality direct submissions
Adherence to ethical and governance policies for the journal
Ensuring the smooth and efficient running of the editorial office in conjunction with the Chief Executive and Managing Editor
Supporting the fulfilment of the marketing objectives of the BJUI journals and its content in conjunction with the Publishers and BJUI Charity
Being accountable to the BJUI Trustees in relation to ethical, governance, strategic and commercial aspects of the journal
Provision of a written Editor’s report for Trustees when requested. Attendance at ad hoc meetings with the Chairman and Chief Executive as necessary.
Should we investigate all patients with haematuria?
11,000 patients, 110 hospitals, 26 countries. Dr Veeru Kasivisvanathan, UCL Division of Surgery & Dr Sinan Khadhouri, University of Aberdeen, present their BJUI paper on the #IDENTIFY_study, revealing the global cancer prevalence and predictors in the largest study of patients referred to hospital with suspected urinary tract cancer ever performed.
Expert in bladder cancer, Prof Stephen Williams, UTMB Health, will host a critical review of the results led by Prof Maria Ribal, Hospital CLÍNIC, Barcelona and Associate Prof Angie Smith, UNC Urology.
15 mins presentation; 30 mins live Q&A; 24hrs online discussion; #BJUI_Webinar
Mr Chuanyu Gao is a Core Surgical Trainee in KSS Deanery. He graduated from UCL Medical School and obtained his iBSc in Surgical Sciences before completing his Academic Foundation Years in East of England Foundation School. Chuanyu first became involved with BURST on the MIMIC Study as an international site coordinator and has been part of the BURST committee ever since.
Taimur T. Shah*†‡§, Chuanyu Gao*, Max Peters¶, Todd Manning**, Sophia Cashman*, Arjun Nambiar*, Marcus Cumberbatch*††, Ben Lamb*, Anthony Peacock‡‡, Marieke J. Van Son¶, Peter S. N. van Rossum¶, Robert Pickard§§, Paul Erotocritou¶¶, Daron Smith***, Veeru Kasivisvanathan*‡ and British Urology Researchers in Surgical Training (BURST) Collaborative MIMIC Study Group
*British Urology Researchers in Surgical Training (BURST), London, UK, †Division of Surgery and Cancer, Imperial College London, ‡Division of Surgery and Interventional Science, University College London, §Charing Cross Hospital, Imperial Health NHS Trust, London, UK, ¶Department of Radiation Oncology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands, **Australian Young Urology Researchers Organisation (YURO), Heidelberg, Victoria, Australia, ††Academic Urology Unit, University of Shefﬁeld, Shefﬁeld, ‡‡Information Services Division, University College London (UCL), London, §§Department of Urology, Newcastle University, Newcastle, UK, ¶¶Department of Urology, Whittington Hospital, and ***Department of Urology, UCL Hospital, London, UK
How time flies! It seems like only yesterday that I was appointed the 10th Editor‐in‐Chief of a 90‐year old major surgical journal. We assembled a dynamic team with a clear, modern vision and strategy. As we say goodbye, it is time to reflect fondly on our achievements.
The most read surgical journal on the web?
Of the many ways to measure this, one is the number of downloads of BJUI articles from our publisher Wiley Online Library. This has increased steadily every year, reaching 3 million downloads in 2019 alone. In addition to this we are regarded as pioneers of web‐based publishing and social media. The BJUI itself and its editorial team have a large, devoted following especially on Twitter. Our infographics, podcasts, picture quizzes, polls and videos were deliberately designed to grab an audience with limited time and short attention spans. The BJUI blogs have often been read more than the articles themselves, bringing immediacy, wider engagement and sensible debate. The most visited blog on the death of Nobel Laureate Tagore from prostatic enlargement was read nearly 110 000 times.
To increase the impact of the BJUI
Our impact factor has steadily increased since 2012, reaching the highest in its history and is as close to 5 as it ever has been. This has been achieved by decreasing the acceptance rate to 10% without any form of manipulation. This means that the BJUI papers are now “returnable” to any research excellence exercise of which many exist worldwide. As a clinician–scientist I could not accept anything else in academic circles. The BJUI is the only surgical journal to be rated in the Altmetric top 50 reaching a score of 1469 , compared to an average Altmetric score of 3. It is a testament to the hard work of our team above and beyond the impact factor. I suspect that with more fully open access journals such as the BJUI Compass , driven by Plan S, the importance of the impact factor as it now stands, may gradually diminish over time. We have also led on bringing innovation such as Artificial Intelligence  into our journal and making science accessible to a clinical audience through our “science made simple” section.
Quality without boundaries
While many of our papers come from the UK, USA and Australia, we have also published the best articles from Uganda, China, Japan, Iran, Korea, India, Pakistan and Peru. We are and remain a global journal, associated with 10 international societies. The NICE guidelines have been well cited over the last 3 years  as have the papers in our Trials section and the ever‐popular Guideline of Guidelines . We have managed to co‐publish a number of high‐quality Cochrane reviews including the only one with a maximum AMSTAR score of 11 out of 11 comparing laparoscopic, robotic and open radical prostatectomy .
In this issue of the BJUI , we have published the protocol and curriculum development of the SIMULATE study – the world’s first and only multi‐centre randomised controlled trial of surgical simulation. What started as a BAUS study, expanded worldwide and recruited 1400 cases to see if simulation made better surgeons and improved patient outcomes .
The BJUI also brought innovative design from the fashion industry into academic publishing through the Glass magazine. As a parting gift, I therefore thought it fitting to publish a photograph of the courtyard of King’s College London where the SIMULATE trial first started. It was taken on a sunny day on my iPhone with no one in sight because of the pandemic. We have seen the viral crisis as an opportunity to learn from other nations and published a critical review to guide urological care for our colleagues, residents and patients .
I take this opportunity to thank a loyal group of friends at the BJUI Editorial offices, our trustees, the Associate and Consulting Editors, our wider editorial team of authors and reviewers and our publisher Wiley. I am proud to hand over the BJUI to my friend Freddie Hamdy in the best state of academic health and creativity.
Every year the BJUI awards three prizes to trainee urologists who have played a significant role in contributing to the work published in the journal. The prizes go towards travel costs enabling the trainees to visit international conferences. In 2020, due to the coronavirus pandemic leading to the cancellation of many of these conferences, the usual prize-giving ceremonies have not taken place so here we are introducing you to the prize winners and their work. We hope they will be able to spend their prize money in 2021.
This is awarded to authors who are trainees based anywhere in the world other than the Americas and Europe. Usually presented at the USANZ annual meeting. In 2020 the prize was awarded to Sho Uehara for his work on artificial intelligence in prostate cancer diagnosis.
Sho Uehara received a Ph.D. from the graduate school of Tokyo Medical and Dental University, Tokyo, Japan, in 2018. He is now working as a urologist and an assistant professor at the university hospital. His research interests include prostate cancer diagnostics, and utilization of machine learning for them.
Membership of academic societies:
JUA (The Japanese Urological Association), EAU (European Association of Urology) and AUA (American Urological Association)
The Coffey-Krane prize is awarded to an author who is a trainee based in The Americas. Normally presented at the AUA annual conference. Dr Nathan Wong received this year’s award for his work on using machine learning to predict biochemical cancer recurrence following prostatectomy.
Dr Nathan Wong is an assistant professor and associate program director in the Department of Urology at Westchester Medical Center and New York Medical College. He specializes in urologic oncology and robotics surgery. His main interests are in technology, clinical trials and surgical education. He completed a Society of Urologic Oncology fellowship at Memorial Sloan Kettering Cancer Center in New York City and urology residency at McMaster University in Hamilton, Ontario in Canada.
John Blandy prize
This prize is for authors who are trainees based in Europe. Presented at the BAUS annual conference; the winner gives a presentation. This year the prize went to Nicholas Raison for his work on a RCT on cognitive training in robotic surgery.
Nicholas Raison is Vattikuti fellow at the MRC Centre for Transplantation and Mucosal Cell Biology, King’s College London and a Urology Specialist Registrar in the London Deanery.
This month, BJUI continues the Four Seasons Peer Reviewer Award recognising the hard work and dedication of our peer reviewers. Each quarter the Editor and Editorial Team select an individual peer reviewer whose reviews over the last 3 months have stood out for their quality and timeliness.
The Summer 2020 crown goes to Houston Thompson
R. Houston Thompson, MD, completed his Urology Residency at Mayo Clinic Rochester in 2007 followed by a Urologic Oncology Fellowship at Memorial Sloan-Kettering Cancer Center. He is currently Professor of Urology at Mayo Clinic Rochester. Dr. Thompson is involved in clinical and translational research in urologic oncology and has >200 peer-reviewed original articles.
Notable contributions to the literature include discovery that PD-1 and PD-L1 are aberrantly expressed in the microenvironment of renal cell carcinoma tumors, and thus represent attractive therapeutic targets. Dr. Thompson is the recipient of the Donald C. Balfour Award for meritorious research from the Mayo Clinic and the Michael E. Burt Award for Clinical Excellence from Memorial Sloan-Kettering Cancer Center.